Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mepivacaine chlorhydrate, an amide local anesthetic related to lidocaine, is combined with sodium bicarbonate (NaHCO₃) to create a buffered solution. This buffering neutralizes the acidic nature of mepivacaine, reducing pain during infiltration while maintaining anesthetic efficacy and duration. The combination is primarily used for local and regional anesthesia, including nerve blocks, infiltration anesthesia, and epidural anesthesia, as well as for dental procedures and specific blocks like axillary brachial plexus, median, and ulnar nerve blocks. It is also used for local infiltration anesthesia in procedures like ambulatory phlebectomies for varicose vein treatment. Studies show benefits including reduced pain during injection and faster onset of action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mepivacaine chlorhydrate + Sodium Bicarbonate.